 | • レポートコード：D0GIR-01523 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、癌ワクチン薬剤パイプラインの世界市場を広く調査・分析し、今後の市場展望をまとめております。癌ワクチン薬剤パイプラインの種類別市場規模（治療ワクチン、予防ワクチン）、用途別市場規模（外来診療センター、病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eisai、Bristol-Myers Squibb、F. Hoffmann-La Roche、Arbor Pharmaceuticals、Merck ・地域別グローバル市場分析 2015年-2020年 ・癌ワクチン薬剤パイプラインの北米市場（アメリカ、カナダ、メキシコ） ・癌ワクチン薬剤パイプラインのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・癌ワクチン薬剤パイプラインのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・癌ワクチン薬剤パイプラインの南米市場（ブラジル、アルゼンチン） ・癌ワクチン薬剤パイプラインの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：治療ワクチン、予防ワクチン ・用途別分析：外来診療センター、病院 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cancer Vaccines Drug Pipeline market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Vaccines Drug Pipeline market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Vaccines Drug Pipeline market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Vaccines Drug Pipeline market has been segmented into:
Therapeutic Vaccine
Prophylactic Vaccine
By Application, Cancer Vaccines Drug Pipeline has been segmented into:
Ambulatory Care Centers
Hospital
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Vaccines Drug Pipeline market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Vaccines Drug Pipeline markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Vaccines Drug Pipeline market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Vaccines Drug Pipeline market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Vaccines Drug Pipeline Market Share Analysis
Cancer Vaccines Drug Pipeline competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Vaccines Drug Pipeline sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Vaccines Drug Pipeline sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Vaccines Drug Pipeline are:
Eisai
Bristol-Myers Squibb
F. Hoffmann-La Roche
Arbor Pharmaceuticals
Merck
Table of Contents
1 Cancer Vaccines Drug Pipeline Market Overview
1.1 Product Overview and Scope of Cancer Vaccines Drug Pipeline
1.2 Classification of Cancer Vaccines Drug Pipeline by Type
1.2.1 Global Cancer Vaccines Drug Pipeline Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Vaccines Drug Pipeline Revenue Market Share by Type in 2019
1.2.3 Therapeutic Vaccine
1.2.4 Prophylactic Vaccine
1.3 Global Cancer Vaccines Drug Pipeline Market by Application
1.3.1 Overview: Global Cancer Vaccines Drug Pipeline Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Ambulatory Care Centers
1.3.3 Hospital
1.4 Global Cancer Vaccines Drug Pipeline Market by Regions
1.4.1 Global Cancer Vaccines Drug Pipeline Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Vaccines Drug Pipeline (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Vaccines Drug Pipeline Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Vaccines Drug Pipeline Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Vaccines Drug Pipeline Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Vaccines Drug Pipeline Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Vaccines Drug Pipeline Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eisai
2.1.1 Eisai Details
2.1.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eisai SWOT Analysis
2.1.4 Eisai Product and Services
2.1.5 Eisai Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche SWOT Analysis
2.3.4 F. Hoffmann-La Roche Product and Services
2.3.5 F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arbor Pharmaceuticals
2.4.1 Arbor Pharmaceuticals Details
2.4.2 Arbor Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arbor Pharmaceuticals SWOT Analysis
2.4.4 Arbor Pharmaceuticals Product and Services
2.4.5 Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Cancer Vaccines Drug Pipeline Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Vaccines Drug Pipeline Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Vaccines Drug Pipeline Players Market Share
3.2.2 Top 10 Cancer Vaccines Drug Pipeline Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Vaccines Drug Pipeline Revenue and Market Share by Regions
4.2 North America Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
5 North America Cancer Vaccines Drug Pipeline Revenue by Countries
5.1 North America Cancer Vaccines Drug Pipeline Revenue by Countries (2015-2020)
5.2 USA Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
6 Europe Cancer Vaccines Drug Pipeline Revenue by Countries
6.1 Europe Cancer Vaccines Drug Pipeline Revenue by Countries (2015-2020)
6.2 Germany Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
6.4 France Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Vaccines Drug Pipeline Revenue by Countries
7.1 Asia-Pacific Cancer Vaccines Drug Pipeline Revenue by Countries (2015-2020)
7.2 China Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
7.5 India Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
8 South America Cancer Vaccines Drug Pipeline Revenue by Countries
8.1 South America Cancer Vaccines Drug Pipeline Revenue by Countries (2015-2020)
8.2 Brazil Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Vaccines Drug Pipeline by Countries
9.1 Middle East & Africa Cancer Vaccines Drug Pipeline Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Vaccines Drug Pipeline Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Vaccines Drug Pipeline Market Forecast by Type (2019-2024)
10.3 Therapeutic Vaccine Revenue Growth Rate (2015-2025)
10.4 Prophylactic Vaccine Revenue Growth Rate (2015-2025)
11 Global Cancer Vaccines Drug Pipeline Market Segment by Application
11.1 Global Cancer Vaccines Drug Pipeline Revenue Market Share by Application (2015-2020)
11.2 Cancer Vaccines Drug Pipeline Market Forecast by Application (2019-2024)
11.3 Ambulatory Care Centers Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
12 Global Cancer Vaccines Drug Pipeline Market Size Forecast (2021-2025)
12.1 Global Cancer Vaccines Drug Pipeline Market Size Forecast (2021-2025)
12.2 Global Cancer Vaccines Drug Pipeline Market Forecast by Regions (2021-2025)
12.3 North America Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
12.6 South America Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Vaccines Drug Pipeline Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Vaccines Drug Pipeline by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Vaccines Drug Pipeline Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Vaccines Drug Pipeline Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eisai Corporate Information, Location and Competitors
Table 6. Eisai Cancer Vaccines Drug Pipeline Major Business
Table 7. Eisai Cancer Vaccines Drug Pipeline Total Revenue (USD Million) (2017-2018)
Table 8. Eisai SWOT Analysis
Table 9. Eisai Cancer Vaccines Drug Pipeline Product and Solutions
Table 10. Eisai Cancer Vaccines Drug Pipeline Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 12. Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Major Business
Table 13. Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Total Revenue (USD Million) (2018-2019)
Table 14. Bristol-Myers Squibb SWOT Analysis
Table 15. Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Product and Solutions
Table 16. Bristol-Myers Squibb Cancer Vaccines Drug Pipeline Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 18. F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Major Business
Table 19. F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Total Revenue (USD Million) (2017-2018)
Table 20. F. Hoffmann-La Roche SWOT Analysis
Table 21. F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Product and Solutions
Table 22. F. Hoffmann-La Roche Cancer Vaccines Drug Pipeline Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Arbor Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Major Business
Table 25. Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Total Revenue (USD Million) (2017-2018)
Table 26. Arbor Pharmaceuticals SWOT Analysis
Table 27. Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Product and Solutions
Table 28. Arbor Pharmaceuticals Cancer Vaccines Drug Pipeline Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Cancer Vaccines Drug Pipeline Major Business
Table 31. Merck Cancer Vaccines Drug Pipeline Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Cancer Vaccines Drug Pipeline Product and Solutions
Table 34. Merck Cancer Vaccines Drug Pipeline Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) by Players (2015-2020)
Table 36. Global Cancer Vaccines Drug Pipeline Revenue Share by Players (2015-2020)
Table 37. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Cancer Vaccines Drug Pipeline Revenue Market Share by Regions (2015-2020)
Table 39. North America Cancer Vaccines Drug Pipeline Revenue by Countries (2015-2020)
Table 40. North America Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Table 41. Europe Cancer Vaccines Drug Pipeline Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Cancer Vaccines Drug Pipeline Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Cancer Vaccines Drug Pipeline Revenue by Countries (2015-2020)
Table 44. South America Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Cancer Vaccines Drug Pipeline Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Table 47. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) by Type (2015-2020)
Table 48. Global Cancer Vaccines Drug Pipeline Revenue Share by Type (2015-2020)
Table 49. Global Cancer Vaccines Drug Pipeline Revenue Forecast by Type (2021-2025)
Table 50. Global Cancer Vaccines Drug Pipeline Revenue by Application (2015-2020)
Table 51. Global Cancer Vaccines Drug Pipeline Revenue Share by Application (2015-2020)
Table 52. Global Cancer Vaccines Drug Pipeline Revenue Forecast by Application (2021-2025)
Table 53. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Vaccines Drug Pipeline Picture
Figure 2. Global Cancer Vaccines Drug Pipeline Revenue Market Share by Type in 2019
Figure 3. Therapeutic Vaccine Picture
Figure 4. Prophylactic Vaccine Picture
Figure 5. Cancer Vaccines Drug Pipeline Revenue Market Share by Application in 2019
Figure 6. Ambulatory Care Centers Picture
Figure 7. Hospital Picture
Figure 8. Global Cancer Vaccines Drug Pipeline Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Cancer Vaccines Drug Pipeline Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Cancer Vaccines Drug Pipeline Revenue Market Share in 2019
Figure 17. Global Top 10 Players Cancer Vaccines Drug Pipeline Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Cancer Vaccines Drug Pipeline Revenue Market Share by Regions (2015-2020)
Figure 21. Global Cancer Vaccines Drug Pipeline Revenue Market Share by Regions in 2018
Figure 22. North America Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 23. Europe Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 25. South America Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 27. North America Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Figure 28. North America Cancer Vaccines Drug Pipeline Revenue Market Share by Countries in 2019
Figure 29. USA Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 30. Canada Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 32. Europe Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Cancer Vaccines Drug Pipeline Revenue Market Share by Countries in 2019
Figure 34. Germany Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 35. UK Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 36. France Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 37. Russia Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 38. Italy Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Cancer Vaccines Drug Pipeline Revenue Market Share by Countries in 2019
Figure 41. China Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 42. Japan Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 43. Korea Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 44. India Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 46. South America Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Figure 47. South America Cancer Vaccines Drug Pipeline Revenue Market Share by Countries in 2019
Figure 48. Brazil Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Cancer Vaccines Drug Pipeline Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Cancer Vaccines Drug Pipeline Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 53. UAE Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Cancer Vaccines Drug Pipeline Revenue and Growth Rate (2015-2020)
Figure 56. Global Cancer Vaccines Drug Pipeline Revenue Share by Type (2015-2020)
Figure 57. Global Cancer Vaccines Drug Pipeline Revenue Share by Type in 2019
Figure 58. Global Cancer Vaccines Drug Pipeline Market Share Forecast by Type (2021-2025)
Figure 59. Global Therapeutic Vaccine Revenue Growth Rate (2015-2020)
Figure 60. Global Prophylactic Vaccine Revenue Growth Rate (2015-2020)
Figure 61. Global Cancer Vaccines Drug Pipeline Revenue Share by Application (2015-2020)
Figure 62. Global Cancer Vaccines Drug Pipeline Revenue Share by Application in 2019
Figure 63. Global Cancer Vaccines Drug Pipeline Market Share Forecast by Application (2021-2025)
Figure 64. Global Ambulatory Care Centers Revenue Growth Rate (2015-2020)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Cancer Vaccines Drug Pipeline Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Cancer Vaccines Drug Pipeline Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
Figure 70. Europe Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
Figure 72. South America Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Cancer Vaccines Drug Pipeline Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
mRNA癌ワクチン及び治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 小分子標的抗癌剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Small Molecule Targeted Anti-cancer Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- mRNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 予防B型肝炎ウイルスワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prophylactic Hepatitis B Virus Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Proph…
- 小分子標的薬物の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Small Molecule Targted Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…